Brief: Kronos Bio Q4 EPS USD -0.43
21/03/2024 11:05
Mar 21 (Reuters) - Kronos Bio Q4 basic EPS USD -0.43. * Q4 net income USD -25.32 million * Q4 operating expenses USD 29.63 million * Q4 operating income USD -27.344 million
Recent news on Kronos Bio
See all newsBrief: Kronos Bio Inc - Terminates Office Lease At 301 Binney Street - SEC Filing
Brief: Kronos Bio Inc - Enters Transition Agreement With Genentech
U.S. STOCKS ON THE MOVE - Ambarella, Dell, Nordstrom
U.S. STOCKS ON THE MOVE - Golden Ocean, Guess, Symbotic
U.S. STOCKS ON THE MOVE-HP, Urban Outfitters, 3D Systems